Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis

Article English RESTRICTED
Kappos, L; Polman, C; Pozzilli, C; Thompson, A; Dahlke, F; Knight, R; Hern, J; Coleman, R; Gerrie, L; Cooper, G; Moore, J; Boringa, J; van Oosten, B; Ronner, H; Schrijver, H; Truyen, L; Montalban, J; Rio, J; Tintore, M; Jacas, C; Marzo, E; Lechner-Scott, J; Lienert, C; Brunnschweiler, H; Hawkins, S; Droogan, A; McDonnell, G; Duddy, M; McKinstry, S; Altenkirch, H; ... view all 50 authors
(1998)
  • Subject: STATUS SCALE EDSS | IMPAIRMENT | UMCG Approved

Background The beneficial effects of interferon beta have only been shown for patients in the relapsing-remitting phase of multiple sclerosis (MS). The role of interferon beta in the treatment of patients who are in the secondary progressive phase of the disease (SP-MS)... View more
Share - Bookmark